Roquefort Therapeutics plc (ROQ.L) LSE

1.90

-0.2(-9.52%)

Updated at October 17 03:23PM

Currency In GBp

Valuation

Market Cap5.25M
Enterprise Value5.31M
P/E Ratio-2.54
PEG Ratio-0.07
Price/Sales Ratio1,107.12
Price/Book Ratio0.5
Enterprise/Revenue1,130.43
Enterprise/EBITDA-2.75

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterDecember 31, 2024

Profitability

Profit Margin-359.66
Operating Margin-413.37

Management Effectiveness

Return On Assets-0.17
Return On Equity-0.2

Income Statement

Revenue0
Revenue/Share0
Gross Profit-16,000
EBITDA-1.11M
Net Income-971,803
Diluted EPS-0.01

Balance Sheet

Total Cash337,112
Total Cash/Share0
Total Debt400,092
Total Debt/Equity0.08
Current Ratio0.63
Book Value Per Share0.04

Price History

52-Week Change-50.65
52-Week High6.78
52-Week Low1.08
Moving Average 50 Days1.82
Moving Average 200 Days1.94

Statistics

Average Volume2.26M
Shares Outstanding157.44M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A